Compound library / Growth Hormone Secretagogue
GHRH analogue, FDA-approved (Egrifta) for reduction of excess visceral fat in HIV-associated lipodystrophy.
| Category | Growth Hormone Secretagogue |
|---|---|
| Typical route | Subcutaneous |
| Half-life | ~26-38 minutes |
| Common dose range | 1-2 mg/day |
| Typical cycle length | 12+ weeks, often continuous |
BioHack Track models Tesamorelin at a half-life of 0.55 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Reconstitute with provided diluent or bacteriostatic water.
Refrigerate after reconstitution.
Monitor IGF-1; avoid if active malignancy.
Track Tesamorelin in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Tesamorelin — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.